Pfizer buys Durham facility as expansion plans continue to unfold

International biopharmaceutical firm Pfizer (NYSE: PFE) is continuing its expansion in the Triangle with the purchase of a Durham property set to be the company’s new location for its clinical manufacturing facility, currently based in Chapel Hill.